130 related articles for article (PubMed ID: 32416580)
1. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
[TBL] [Abstract][Full Text] [Related]
2. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.
Gao X; Li G; Deng H; Feng W; Li Y; Liu M; Li Y
Stem Cell Res; 2021 May; 53():102388. PubMed ID: 34088015
[TBL] [Abstract][Full Text] [Related]
3. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
[TBL] [Abstract][Full Text] [Related]
5. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
[TBL] [Abstract][Full Text] [Related]
6. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
7. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
8. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
Ma Y; Wang Z; Liu X; Sun W; Gong Y; Liu G; Sun G
Stem Cell Res; 2021 Apr; 52():102237. PubMed ID: 33601099
[TBL] [Abstract][Full Text] [Related]
10. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
[TBL] [Abstract][Full Text] [Related]
11. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
12. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient.
Guo X; Ji W; Niu C; Ding Y; Chen Z; Chen C; Tong H; Han Z; Chu M
Stem Cell Res; 2020 Dec; 49():102085. PubMed ID: 33202306
[TBL] [Abstract][Full Text] [Related]
13. Female X-linked Alport syndrome with somatic mosaicism.
Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
[TBL] [Abstract][Full Text] [Related]
14. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
[TBL] [Abstract][Full Text] [Related]
15. Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.
Okamoto T; Nozu K; Iijima K; Ariga T
J Nephrol; 2019 Feb; 32(1):155-159. PubMed ID: 30062677
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
17. Twenty-one novel mutations identified in the COL4A5 gene in Chinese patients with X-linked Alport's syndrome confirmed by skin biopsy.
Ma J; Pan X; Wang Z; Wang Y; Feng X; Ren H; Zhang W; Chen X; Wang W; Chen N
Nephrol Dial Transplant; 2011 Dec; 26(12):4003-10. PubMed ID: 21505094
[TBL] [Abstract][Full Text] [Related]
18. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
Wang Y; Zhang H; Ding J; Wang F
Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cell line (NCKDi001-A) from a 19-year-old patient with a novel COL4A5 gene mutation in Alport syndrome.
Wang G; Wu H; Gao E; Zhang L; Chen L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2020 Dec; 49():102023. PubMed ID: 33128955
[TBL] [Abstract][Full Text] [Related]
20. The Alport syndrome COL4A5 variant database.
Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
